DK0885191T3 - Opspaltning af threo-methylphenidat - Google Patents

Opspaltning af threo-methylphenidat

Info

Publication number
DK0885191T3
DK0885191T3 DK97906283T DK97906283T DK0885191T3 DK 0885191 T3 DK0885191 T3 DK 0885191T3 DK 97906283 T DK97906283 T DK 97906283T DK 97906283 T DK97906283 T DK 97906283T DK 0885191 T3 DK0885191 T3 DK 0885191T3
Authority
DK
Denmark
Prior art keywords
threo
methylphenidate
cleavage
proceeds
single enantiomer
Prior art date
Application number
DK97906283T
Other languages
Danish (da)
English (en)
Inventor
Hooshang Shahriari Zavareh
Original Assignee
Medeva Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604943.2A external-priority patent/GB9604943D0/en
Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd
Application granted granted Critical
Publication of DK0885191T3 publication Critical patent/DK0885191T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0004—Crystallisation cooling by heat exchange
    • B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Read Only Memory (AREA)
DK97906283T 1996-03-08 1997-03-07 Opspaltning af threo-methylphenidat DK0885191T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9604943.2A GB9604943D0 (en) 1996-03-08 1996-03-08 Resolution
US1698696P 1996-05-07 1996-05-07
PCT/GB1997/000643 WO1997032851A1 (fr) 1996-03-08 1997-03-07 Resolution de threo-methylphenidate

Publications (1)

Publication Number Publication Date
DK0885191T3 true DK0885191T3 (da) 2002-05-06

Family

ID=26308891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97906283T DK0885191T3 (da) 1996-03-08 1997-03-07 Opspaltning af threo-methylphenidat

Country Status (11)

Country Link
EP (1) EP0885191B1 (fr)
JP (1) JP4138005B2 (fr)
KR (1) KR100459149B1 (fr)
AT (1) ATE212336T1 (fr)
AU (1) AU700836B2 (fr)
CA (1) CA2243542C (fr)
DE (1) DE69710051T2 (fr)
DK (1) DK0885191T3 (fr)
ES (1) ES2173422T3 (fr)
PT (1) PT885191E (fr)
WO (1) WO1997032851A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
GB9700912D0 (en) 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6100401A (en) * 1998-04-20 2000-08-08 Novartris Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride
US6162919A (en) * 1998-12-03 2000-12-19 Novartis Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride
US7229557B2 (en) 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
US8552030B2 (en) 2009-05-07 2013-10-08 Malladi Drugs & Pharmaceuticals Ltd. Process for the preparation of d-threo-ritalinic acid hydrochloride by resolution of dl-threo-ritalinic acid using chiral carboxylic acid
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
AU2012230733B2 (en) 2011-03-23 2016-10-20 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4196303A (en) * 1978-03-20 1980-04-01 Scm Corporation d-Isomenthoxyacetic acid
JPS5538363A (en) * 1978-09-13 1980-03-17 Yoshitomi Pharmaceut Ind Ltd Preparation of optically active n-mercaptoacyl-imino acid

Also Published As

Publication number Publication date
WO1997032851A1 (fr) 1997-09-12
CA2243542C (fr) 2003-02-18
AU700836B2 (en) 1999-01-14
JP2000506162A (ja) 2000-05-23
EP0885191A1 (fr) 1998-12-23
ATE212336T1 (de) 2002-02-15
AU2102497A (en) 1997-09-22
JP4138005B2 (ja) 2008-08-20
KR19990087441A (ko) 1999-12-27
ES2173422T3 (es) 2002-10-16
DE69710051D1 (de) 2002-03-14
EP0885191B1 (fr) 2002-01-23
CA2243542A1 (fr) 1997-09-12
MX9807266A (fr) 1999-08-31
PT885191E (pt) 2002-06-28
DE69710051T2 (de) 2002-08-14
MX202728B (fr) 2001-06-29
KR100459149B1 (ko) 2005-06-10

Similar Documents

Publication Publication Date Title
DK0885191T3 (da) Opspaltning af threo-methylphenidat
NO20000935L (no) Fremgangsmåte for inhibering av komplementaktivering via den alternative reaksjonsvei
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
DK0841928T3 (da) Sustained release-formulering af d-threo-methylphenidat
ATE201203T1 (de) Chirale methylphenyloxazolidinone
BR0209554A (pt) Métodos para a preparação de um composto, e composto
EE04491B1 (et) (+)-nortsisapriidi kasutamine
BR0007643A (pt) Processo para obter ésteres de (nitroximetil) fenila de derivados de aspirina, e, (hidroximetil) feniléter de derivados de aspirina
ATE253037T1 (de) Verfahren zur racematspaltung von tramadol
DK1097130T3 (da) Fremgangsmåde til fremstilling af hydroxymethylthiosmörsyre
AU6578400A (en) Novel method for preparing benzoperhydroisoindole compounds
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ES2190602T3 (es) Procedimiento para la obtencion de los acidos 3-ciano-2,4-dihalogeno-5-fluor-benzoicos.
AU2001250429A1 (en) Method for producing 2-alkyl-3-chlorophenols
TWI255812B (en) A process for the preparation of r-(+)-6-carboxamido-3-n-methylamino-1,2,3,4-tetrahydrocarbazole
EA199900282A2 (ru) Способ получения феноксифенилсульфонилгалогенидов
DK1196415T3 (da) Fremgangsmåde til fremstilling af lysergsyre
BG104964A (bg) Подобрен метод за получаване на фармацевтично ценни норбензоморфанови производни
ATE236135T1 (de) Verfahren zur herstellung von 4,6- dichlorpyrimidin
DK1444244T3 (da) Fremgangsmåde til fremstilling af desclarithromycin, samt mellemprodukter
ECSP992910A (es) Procedimiento para alquilar sulfonamidas impedidas estericamente
GR890100208A (el) Νέα μέθοδος παρασκευής παραγώγων ιμιδαζοπυριδινών.